Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes

THURSDAY, Sept. 19, 2019 -- Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal of the American Medical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news